Patent applications and USPTO patent grants for Swedish Orphan Biovitrum AB (publ).The latest application filed is for "il-ir-i binding polypeptide".
Patent | Date |
---|---|
Compositions comprising anakinra Grant 11,324,807 - Florin-Robertsson , et al. May 10, 2 | 2022-05-10 |
Il-ir-i Binding Polypeptide App 20210403533 - Feldwisch; Joachim ;   et al. | 2021-12-30 |
Syringe plunger rod Grant 11,191,903 - Fransson , et al. December 7, 2 | 2021-12-07 |
Fusion Protein With Half-life Extending Polypeptide App 20210284690 - Nilsson; Joakim ;   et al. | 2021-09-16 |
Methods Of Reducing Aggregation Of Il-1ra App 20210121571 - RAIBEKAS; Andrei ;   et al. | 2021-04-29 |
Syringe Assembly With Ion-Exchange Material App 20200306138 - FRANSSON; Jonas | 2020-10-01 |
Methods of reducing aggregation of IL-1ra Grant 10,765,747 - Raibekas , et al. Sep | 2020-09-08 |
Polypeptides Binding To Human Complement C5 App 20190167760 - Berghard; Charlotta ;   et al. | 2019-06-06 |
Polypeptides binding to human complement C5 Grant 10,206,975 - Berghard , et al. Feb | 2019-02-19 |
Citrate free pharmaceutical compositions comprising anakinra Grant 10,179,162 - Fransson , et al. Ja | 2019-01-15 |
Modified Sulfamidase And Production Thereof App 20180320152 - BERGHARD; Charlotta ;   et al. | 2018-11-08 |
Modified Iduronate 2-sulfatase And Production Thereof App 20180264089 - Nordling; Erik ;   et al. | 2018-09-20 |
Modified Lysosomal Protein And Production Thereof App 20180258408 - Nordling; Erik ;   et al. | 2018-09-13 |
Stable polypeptides binding to human complement C5 Grant 9,994,626 - Nilsson , et al. June 12, 2 | 2018-06-12 |
Modified sulfamidase and production thereof Grant 9,982,243 - Berghard , et al. May 29, 2 | 2018-05-29 |
Compositions Comprising Anakinra App 20180110836 - Florin-Robertsson; Ebba ;   et al. | 2018-04-26 |
Polypeptides Binding To Human Complement C5 App 20180085428 - Berghard; Charlotta ;   et al. | 2018-03-29 |
Polypeptides binding to human complement C5 Grant 9,808,502 - Berghard , et al. November 7, 2 | 2017-11-07 |
Syringe Plunger Rod App 20170028135 - FRANSSON; Jonas ;   et al. | 2017-02-02 |
Stable Polypeptides Binding To Human Complement C5 App 20160311870 - Nilsson; Joakim ;   et al. | 2016-10-27 |
Modified Sulfamidase And Production Thereof App 20160230155 - BERGHARD; Charlotta ;   et al. | 2016-08-11 |
Citrate Free Pharmaceutical Compositions Comprising Anakinra App 20160045568 - FRANSSON; Jonas ;   et al. | 2016-02-18 |
Citrate free pharmaceutical compositions comprising anakinra Grant 9,198,954 - Fransson , et al. December 1, 2 | 2015-12-01 |
Method To Increase The Absorption Of Unsaturated Fatty Acids By Human Infants App 20150297683 - HERNELL; Olle ;   et al. | 2015-10-22 |
Method To Increase The Growth Velocity Of Human Infants App 20150283215 - HERNELL; Olle ;   et al. | 2015-10-08 |
Formulations Of Recombinant Human Bile Salt-stimulated Lipase App 20150191714 - Ek; Vilhelm | 2015-07-09 |
Method to increase the absorption of unsaturated fatty acids by human infants Grant 8,986,682 - Hernell , et al. March 24, 2 | 2015-03-24 |
Low Ph Protein Purification Process App 20140186921 - Stromquist; Thomas ;   et al. | 2014-07-03 |
Citrate Free Pharmaceutical Compositions Comprising Anakinra App 20140018298 - Fransson; Jonas ;   et al. | 2014-01-16 |
Therapeutic formulations of keratinocyte growth factor Grant 8,304,387 - Treuheit , et al. November 6, 2 | 2012-11-06 |
Method to Increase the Absorption of Unsaturated Fatty Acids by Human Infants App 20120100127 - Hernell; Olle ;   et al. | 2012-04-26 |
Method to Increase the Growth Velocity of Human Infants App 20120100126 - Hernell; Olle ;   et al. | 2012-04-26 |
NCAGE Code | A261N | SWEDISH ORPHAN BIOVITRUM AB (PUBL) |
NCAGE Code | SGP97 | SWEDISH ORPHAN BIOVITRUM AB (PUBL) |
CAGE Code | SGP97 | SWEDISH ORPHAN BIOVITRUM AB (PUBL) |
CAGE Code | A261N | SWEDISH ORPHAN BIOVITRUM AB (PUBL) |
SEC | 0001789731 | Swedish Orphan Biovitrum AB (publ) of SWEDEN |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.